Delivery Order SPE2DB20D3101-SPE2DB25FRAR9
Award Date
1/31/25
Potential Completion Date
2/3/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,239.60 firm fixed-price contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of November 1, 2024 and was awarded on October 31, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,625.56, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of January 15, 2025. The award was made on January 14, 2025, and there was no set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.62 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $45,877.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a completion date of January 21, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,511.62, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of December 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,968.88, is a Firm Fixed Price Delivery Order for the medical product GEMTESA 75 MG TABLET 90S. The contract has a period of performance through December 10, 2024 and was awarded on December 9, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,664.19, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The delivery order is valued at $8,058.59 and has a completion date of September 25, 2024. It is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of GEMTESA 75 MG TABLET 90S, a medical product. The contract has a ceiling value of $38,908.11 and an ultimate completion date of December 5, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $60,162.68 and is a firm fixed-price contract. The award date is July 24, 2024, and the ultimate completion date is July 25, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of prescription...